Bio-Techne Corporation
$72.68
−0.01 · −0.02% today
Market open · updated 12:42:21 PM ET
- High
- $72.70 2:05 PM
- Low
- $72.63 3:10 PM
Against the S&P 500 Price change through Oct 27, 2026
TECH+23.45%
S&P 500+12.87%
TECH+13.00%
S&P 500+12.32%
TECH+21.93%
S&P 500+87.41%
TECH−43.03%
S&P 500+69.55%
Key numbers
- Previous close
- $72.69
- Open
- $72.64
- Day's range
- $72.64 – $72.73
- 52-week range
- $43.20 – $72.75
- Volume
- 1.3 million
- Average volume
- 4.2 million
- Market value
- $11.4 billion
- Price to earnings
- 62.1last 12 months
- Earnings per share
- $1.17last 12 months
- Beta
- 1.29moves about 1.3× as much as the market
- Dividend
- $0.32 a year · 0.44%
- 50-day average
- $72.44
- 200-day average
- $63.10
Wednesday, Nov 4, 2026, before the open.
Analyst price targets and the full financials are in the terminal.
Who Bio-Techne buys from and competes with From our value chain
Bio-Techne in the news
- Company earningsThermo Fisher Scientific tops Q3 estimates, but shares slide premarketWiseView Research desk · October 21, 2026
- CongressApril McClain Delaney sold $1,001 - $15,000 of TECHHouse filing · disclosed May 7, 2026
- CongressApril McClain Delaney sold $1,001 - $15,000 of TECHHouse filing · disclosed Apr 8, 2026
- CongressApril McClain Delaney sold $1,001 - $15,000 of TECHHouse filing · disclosed Mar 11, 2026
- CongressApril Delaney sold $1,001 - $15,000 of TECHHouse filing · disclosed Feb 3, 2026
- CongressApril Delaney bought $1,001 - $15,000 of TECHHouse filing · disclosed Jan 6, 2026
- CongressApril Delaney bought $1,001 - $15,000 of TECHHouse filing · disclosed Jan 6, 2026
- CongressApril Delaney bought $1,001 - $15,000 of TECHHouse filing · disclosed Nov 5, 2025
Earnings
Next report: Wednesday, Nov 4, 2026, before the open.
Congress trades in TECH
3 purchases and 5 sales in the latest 8 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| April McClain DelaneyHouse · D-Maryland | Sale | $1,001 - $15,000 | Apr 8, 2026 | May 7, 2026 |
| April McClain DelaneyHouse · D-Maryland | Sale | $1,001 - $15,000 | Mar 26, 2026 | Apr 8, 2026 |
| April McClain DelaneyHouse · D-Maryland | Sale | $1,001 - $15,000 | Feb 24, 2026 | Mar 11, 2026 |
| April DelaneyHouse | Sale | $1,001 - $15,000 | Jan 28, 2026 | Feb 3, 2026 |
| April DelaneyHouse | Purchase | $1,001 - $15,000 | Dec 5, 2025 | Jan 6, 2026 |
| April DelaneyHouse | Purchase | $1,001 - $15,000 | Dec 2, 2025 | Jan 6, 2026 |
| April DelaneyHouse | Purchase | $1,001 - $15,000 | Oct 22, 2025 | Nov 5, 2025 |
| April DelaneyHouse | Sale | $1,001 - $15,000 | Aug 1, 2025 | Sep 3, 2025 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Bio-Techne
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology.
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 3,000
- Headquarters
- Minneapolis, Minnesota
- Website
- bio-techne.com
- Listed
- Feb 9, 1989
More biotechnology stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.